160 mg BERLEX (Betapace AF 160 mg)
Generic Name: sotalol
Pill imprint 160 mg BERLEX has been identified as Betapace AF 160 mg.
Betapace AF is used in the treatment of atrial fibrillation; atrial flutter and belongs to the drug classes group III antiarrhythmics, non-cardioselective beta blockers. There is no proven risk in humans during pregnancy. Betapace AF 160 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- sotalol
- Imprint:
- 160 mg BERLEX
- Strength:
- 160 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Group III antiarrhythmics
Non-cardioselective beta blockers - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Berlex Laboratories
- National Drug Code (NDC):
- 50419-0116
- Inactive Ingredients:
- silicon dioxide
lactose
magnesium stearate
microcrystalline cellulose
corn starch
stearic acid
More about Betapace AF (sotalol)
Consumer resources
- Other brands: Sotalol Hydrochloride AF, Sorine, Sotylize
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
